Colorectal Cancer Organoid Model Reveals the Mechanisms of Irinotecan Resistance at Single‐Cell Resolution
Cancer Medicine · 2026
DOI: 10.1002/cam4.71550 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2026. Verfasst von Yi Pan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Central Laboratory and Precision Medicine Center, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang Province, Chin…. Hauptthemen laut MEDLINE: Irinotecan, Drug Resistance, Neoplasm, Colorectal Neoplasms, Organoids. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Jinhua Science and Technology Bureau, Health Commission of Zhejiang Province, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Objective
Irinotecan, a standard therapeutic agent for metastatic colorectal cancer (mCRC), often faces significant limitations due to drug resistance, with treatment failure observed in approximately 30%–50% of patients, leading to poor clinical outcomes. This study aims to systematically elucidate the molecular mechanisms underlying irinotecan resistance in colorectal cancer (CRC) by constructing patient‐derived organoid (PDO) models combined with single‐cell transcriptomics technology.
Methods
PDO models were successfully established from irinotecan‐resistant and sensitive CRC patients. Single‐cell RNA sequencing (scRNA‐seq) was performed on the organoids, analyzing the transcriptomic heterogeneity of 12,360 high‐quality cells. Gene Set Variation Analysis (GSVA), transcriptional regulatory networks, and cell communication networks were employed to dissect the resistance mechanisms.
Results
Drug sensitivity assays demonstrated that the IC 50 value of irinotecan in CRC5 was significantly higher than that in CRC11, which was entirely consistent with their respective clinical phenotypes. Single‐cell sequencing identified CRC5‐specific drug‐resistant cell clusters, Cluster 1 and Cluster 6. Cluster 1 (MARCKSL1+) was characterized by the activation of the Wnt signaling pathway and extracellular matrix (ECM) remodeling, which collectively contributed to the maintenance of stem cell‐like properties, while Cluster 6 (AKR1C3+) exhibited significant enrichment in lipid metabolism and the Notch signaling pathway.
Conclusion
This study integrates PDO models with single‐cell transcriptomics technology to reveal key cell subpopulations and molecular mechanisms underlying irinotecan resistance. The core mechanisms driving resistance involve the activation of Wnt signaling and the synergistic effect of lipid metabolism‐Notch pathways. Cluster 1 and Cluster 6 are identified as potential therapeutic targets, providing a theoretical basis for developing combination therapies targeting cancer stem cells or the metabolic microenvironment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Central Laboratory and Precision Medicine Center, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang Province, China.
- Jinhua Key Laboratory of Cancer Nutrition and Metabolism Research, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang Province, China.
- Department of Oncology, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang Province, China.
- Department of Colorectal Surgery, Affiliated Jinhua Hospital, Zhejiang University School of Medicine, Jinhua, Zhejiang Province, China.
ORCID-Profile: Jinlin Du
Förderung
- Jinhua Science and Technology Bureau
- Health Commission of Zhejiang Province
- Natural Science Foundation of Zhejiang Province
- Emerging Medical Talent of Zhejiang Provincial Health Commission
Zitieren
APA
Pan, Y., Chen, L., Hu, Y., Chang, J., Xu, X., Xu, S., Li, Y., Du, J., Wang, J., & Xu, W. (2026). Colorectal Cancer Organoid Model Reveals the Mechanisms of Irinotecan Resistance at Single‐Cell Resolution. Cancer Medicine. https://doi.org/10.1002/cam4.71550
Vancouver
Pan Y, Chen L, Hu Y, Chang J, Xu X, Xu S, et al. Colorectal Cancer Organoid Model Reveals the Mechanisms of Irinotecan Resistance at Single‐Cell Resolution. Cancer Medicine. 2026. doi:10.1002/cam4.71550
BibTeX
@article{Pan2026,
author = {Pan, Yi and Chen, Lin and Hu, Yuqing and Chang, Jie and Xu, Xifeng and Xu, ShuoChen and Li, YiWen and Du, Jinlin and Wang, JianPing and Xu, Wenxia},
title = {Colorectal Cancer Organoid Model Reveals the Mechanisms of Irinotecan Resistance at Single‐Cell Resolution},
journal = {Cancer Medicine},
year = {2026},
doi = {10.1002/cam4.71550}
}
EUVIMED